Association of soluble adhesion molecule and C-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes

Current Neurovascular Research

Volumn 5, Issue 2, 2008, Pages 106-111

  Umemura, Toshitaka ^a   Kawamura, Takahiko ^a   Sakakibara, Toshimasa ^a   Kanai, Akio ^a   Sano, Takahisa ^a   Hotta, Nigishi ^a   Sobue, Gen ^b  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Diabetes mellitus; Endothelial dysfunction; hs CRP; Intima media thickness; Silent brain infarction

Indexed keywords

BRAIN PROTEIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; B SCAN; BRAIN INFARCTION; COMMON CAROTID ARTERY; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOENCEPHALOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

AGED; BRAIN INFARCTION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ULTRASONOGRAPHY;

EID: 45249119551     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720208784310213     Document Type: Article

References (27)

1. Bernick, C, Kuller, L, Dulberg, C, Longstreth, WT Jr, Manolio, T, Beauchamp, N, Price, T. (2001) Silent MRI infarcts and the risk of future stroke: The cardiovascular health study. Neurology 57: 1222-1229.
2. Blankenberg, S, Barbaux, S, Tiret, L. (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170: 191-203.
3. Carter, AM, Grant, PJ. (1997) Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diabetic Med 14: 423-432.
4. Curb, JD, Abbott, RD, Rodriguez, BL, Sakkinen, P, Popper, JS, Yano, K, Tracy, RP. (2003) C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107: 2016-2020.
5. Dietrich, JB. (2002) The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol 128: 58-68.
6. Frijns, CJM, Kappelle, LJ. (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33: 2115-2122.
7. Hassan, A, Hunt, BJ, O'Sullivan, M, Parmar, K, Bamford, JM, Briley, D, Brown, MM, Thomas, DJ, Markus, HS. (2003) Markers of endothelial dysfunction in lacunar infarction and ischemic leukoaraiosis. Brain 126: 424-432.
8. Hoshi, T, Kitagawa, K, Yamagami, H, Furukado, S, Hougaku, H, Hori M. (2005) Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36: 768-772.
9. Inoue, K, Matsumoto, M, Shono, T, Toyokawa, S, Moriki, A. (2007) Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis 16(1): 14-20.
10. Ishikawa, J, Tamura, Y, Hoshide, S, Eguchi, K, Ishikawa, S, Shimada, K, Kario, K. (2007) Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives. The Jichi Medical School ABPM Study, Wave 1. Stroke 38: 911-917.
11. Kawamura, T, Umemura, T, Kanai, A, Uno, T, Matsumae, H, Sano, T, Sakamoto, N, Sakakibara, T, Nakamura, J, Hotta N. (1998) The incidence and characteristics of silent cerebral infarction in elderly diabetic patients;association with serum soluble adhesion molecules. Diabetologia 41: 911-917.
12. Lindsberg, PJ, Carpén, O, Paetau, A, Karjalainen-Lindsberg, ML, Kaste, M. (1996) Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94 : 939-945.
13. Markus, HS, Hunt, B, Palmer, K, Enzinger, C, Schmids, H, Schmids, R. (2005) Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the Austrian Stroke Prevention Study. Stroke 36: 1410-1414.
14. Millikan, C, Futrell, N. (1990) The fallacy of the lacune hypothesis. Stroke 21: 1251-1257.
15. Otsuki, M, Hashimoto. K, Morimoto. Y, Kishimoto. T, Kasayama. S. (1997) Circulating vascular cell adhesion molecule-1(VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46: 2096-2101.
16. Rost, NS, Wolf, PA, Kase, CS, Kelly-Hayes, M, Silbershatz, H, Massaro, JM, D'Agostino, RB, Franzblau, C, Wilson, PWF. (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32: 2575-2579.
17. Shinkawa, A, Ueda, K, Kiyohara, Y, Kato, I, Sueishi, K, Tsuneyoshi, M, Fujishima, M. (1995) Silent cerebral infarction in a community-based autopsy series in Japan.The Hisayama study. Stroke 26: 380-385.
18. Starr, JM, Wardlaw, J, Ferguson, K, MacLullich, A, Deary, IJ, Marshall, I. (2002) Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74: 70-76.
19. Tanne, D, Haim, M, Boyko, V, Goldbourt, U, Reshef, T, Matetzky, S, Adler, Y, Mekori, YA, Behar, S. (2002) Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke. A nested case- control study from the bezafibrate infarction prevention (BIP) study cohort. Stroke 33: 2182-2186.
20. Uehara, T, Tabuchi, M, Mori, E. (1999) Risk factors for silent cerebral infarcts in subcortical white matter and basal gangia. Stroke 30: 378-382.
21. van Dijk, EJ, Prins, ND, Vermeer ,SE, Vrooman, HA, Hofman, A, Koudstaal, PJ, Breteler, MMB. (2005) C-reactive protein and cerebral small-vessel disease:The Rotterdam scan study. Circulation 112: 900-905.
22. Vermeer, SE, Koudstaal, PJ, Oudkerk, M, Hofman, A, Breteler, MMB. (2002) Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33: 21-25.
23. Vermeer, SE, Hollander, M, van Dijk, EJ, Hofman , A, Koudstaal, PJ, Breteler, MMB. (2003a) Silent brain infarcts and white matter leisions increase stroke risk in the general Population. Stroke 34: 1126-1129.
24. Vermeer, SE, Prins, ND, den Hijer, T, Hofman, A, Koudstaal, PJ, Breteler, MMB. (2003b) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-1222.
25. Vermeer, SE, den Heijer, T, Koudstaal, PJ, Oudkerk, M, Hofman, A, Breteler, MMB. (2003c) Incidence and risk factors of silent brain infarcts in the population-based Rotterdam study. Storke 34: 392-396.
26. Wang, TJ, Nam, B-H, Wilson, PWF, Levy, WD, Polak, JF, D'Agostino, RB, O'Donnell, CJ. (2002) Association of C-reactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 22: 1662-1667.
27. Winbeck, K, KuKla, C, Poppert, H, Klingenlhofer, J, Conrad, B, Sander, D. (2002) Elevated C-reactive protein in associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 13: 57-63.